JUST IN
You are here » Home » Companies » Company Overview » Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd.

BSE: 532989 Sector: Health care
NSE: BAFNAPHARM ISIN Code: INE878I01014
BSE 00:00 | 20 Apr 29.00 0.25
(0.87%)
OPEN

28.00

 HIGH

29.00

 LOW

28.00
NSE 00:00 | 20 Apr 28.95 -0.40
(-1.36%)
OPEN

29.50

 HIGH

29.50

 LOW

28.90
Add to Watchlist  |   Add to Portfolio
OPEN 28.00
PREVIOUS CLOSE 28.75
VOLUME 1188
52-Week high 32.40
52-Week low 20.00
P/E 5.79
Mkt Cap.(Rs cr) 54
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 28.00
CLOSE 28.75
VOLUME 1188
52-Week high 32.40
52-Week low 20.00
P/E 5.79
Mkt Cap.(Rs cr) 54
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
Filter:

Bafna Pharmaceuticals Ltd. (BAFNAPHARM) - Nine Monthly Result

Particulars ( cr) Dec '17 Dec '16 Dec '15 Dec '14 Dec '13
Net Sales/Income From Operations 30.65 53.52 59.04 123.80 138.25
Other Income 30.33 1.15 1.22 0.73 1.03
Total Income 60.98 54.67 60.26 124.53 139.28
Total Expenditure 32.89 52.69 53.73 77.68 121.07
Operating Profit 28.09 1.98 6.52 46.85 18.21
Interest 5.78 9.19 9.04 9.79 8.66
Gross Profit 22.30 -7.21 -2.52 37.06 9.55
Depreciation 2.88 3.05 2.35 4.88 4.50
PBT 17.72 -10.10 -4.87 32.18 5.05
Tax 0.00 0.00 0.47 3.30 1.71
Net Profit/(Loss) 17.72 -10.10 -5.34 28.88 3.34
Minority Interest After NP - - - - -
Net Profit after Minority Interest - - - - -
Exceptional Items 0.00 0.00 0.00 -2.41 0.00
Profit After Exceptional Items 17.72 -10.10 -5.34 31.29 3.34
Equity Share Capital 18.66 18.66 18.66 18.66 18.66
Reserves Excluding Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
EPS
Basic EPS 9.50 -5.41 -2.86 15.48 1.79
Public Share Holding
No Of Shares (Crores) 0 0 0 0.12 1.18
Share Holding (%) 0.00 0.00 0.00 63.05 63.50
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of Shares (Crores) 0 0 0 0.15 0.15
- Per. of Shares (as a % of the total sh. of prom. and promoter group) 0.00 0.00 0.00 22.19 22.47
- Per. of Shares (as a % of the total Share Cap. of the company) 0.00 0.00 0.00 8.20 8.20
b) Non-encumbered
- Number of Shares (Crores) 0 0 0 0.54 0.53
- Per. of shares (as a % of the total sh. of prom. and promoter group) 0.00 0.00 0.00 77.81 77.53
- Per. of shares (as a % of the total Share Cap. of the company) 0.00 0.00 0.00 28.75 28.30
Note : PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure.
Next

Browse STOCK Companies

Quick Links for Bafna Pharmaceuticals: